0001714899-23-000108.txt : 20230719
0001714899-23-000108.hdr.sgml : 20230719
20230719170914
ACCESSION NUMBER: 0001714899-23-000108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230717
FILED AS OF DATE: 20230719
DATE AS OF CHANGE: 20230719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SATO VICKI L
CENTRAL INDEX KEY: 0001197020
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 231097431
MAIL ADDRESS:
STREET 1: 940 WINTER STREET
STREET 2: PERKINELMER, INC. LEGAL DEPARTMENT
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Denali Therapeutics Inc.
CENTRAL INDEX KEY: 0001714899
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463872213
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 866-8548
MAIL ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
wk-form4_1689800946.xml
FORM 4
X0508
4
2023-07-17
0
0001714899
Denali Therapeutics Inc.
DNLI
0001197020
SATO VICKI L
C/O DENALI THERAPEUTICS INC.
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
1
Common Stock
2023-07-17
4
S
0
1666
29.60
D
133037
D
The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.35 to $29.94 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Includes 4,216 RSUs.
/s/ Alexander Schuth, by power of attorney
2023-07-19